| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |